Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls

Ilir Agalliu, Roberto A. Ortega, Marta San Luciano, Anat Mirelman, Claustre Pont-Sunyer, Kathrin Brockmann, Dolores Vilas, Eduardo Tolosa, Daniela Berg, Bjørg Warø, Amanda Glickman, Deborah Raymond, Rivka Inzelberg, Javier Ruiz-Martinez, Elisabet Mondragon, Eitan Friedman, Sharon Hassin-Baer, Roy N. Alcalay, Helen Mejia-Santana, Jan AaslyTatiana Foroud, Karen Marder, Nir Giladi, Susan Bressman, Rachel Saunders-Pullman

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls'. Together they form a unique fingerprint.

Medicine & Life Sciences